Arginine is a disease modifier for polyQ disease models that stabilizes polyQ protein conformation
出版年份 2020 全文链接
标题
Arginine is a disease modifier for polyQ disease models that stabilizes polyQ protein conformation
作者
关键词
-
出版物
BRAIN
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2020-03-27
DOI
10.1093/brain/awaa115
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Spinocerebellar ataxias: prospects and challenges for therapy development
- (2018) Tetsuo Ashizawa et al. Nature Reviews Neurology
- iPatax: iPad® application software for evaluating ataxia
- (2017) T. Nagai et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Neuroprotective Role of Agmatine in Neurological Diseases
- (2017) Weilin Xu et al. Current Neuropharmacology
- Arginine Metabolism Revisited
- (2016) Sidney M Morris JOURNAL OF NUTRITION
- Recommendations for the Management of Strokelike Episodes in Patients With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Strokelike Episodes
- (2016) Mary Kay Koenig et al. JAMA Neurology
- Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled A , tau, and -synuclein
- (2015) M. Goedert SCIENCE
- p62 Plays a Protective Role in the Autophagic Degradation of Polyglutamine Protein Oligomers in Polyglutamine Disease Model Flies
- (2014) Yuji Saitoh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The therapeutic potential of chemical chaperones in protein folding diseases
- (2014) Leonardo Cortez et al. Prion
- Inhibiting toxic aggregation of amyloidogenic proteins: A therapeutic strategy for protein misfolding diseases
- (2013) Biao Cheng et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Creatine metabolism in urea cycle defects
- (2012) Sara Boenzi et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Perspectives on molecular targeted therapies and clinical trials for neurodegenerative diseases
- (2012) Masahisa Katsuno et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
- (2012) Iryna Benilova et al. NATURE NEUROSCIENCE
- Drug repositioning for Alzheimer's disease
- (2012) Anne Corbett et al. NATURE REVIEWS DRUG DISCOVERY
- Hsp40 Gene Therapy Exerts Therapeutic Effects on Polyglutamine Disease Mice via a Non-Cell Autonomous Mechanism
- (2012) H. Akiko Popiel et al. PLoS One
- Simultaneous determination of hydrophilic amino acid enantiomers in mammalian tissues and physiological fluids applying a fully automated micro-two-dimensional high-performance liquid chromatographic concept
- (2009) Kenji Hamase et al. JOURNAL OF CHROMATOGRAPHY A
- The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies
- (2009) Peter O. Bauer et al. JOURNAL OF NEUROCHEMISTRY
- Conformational Changes and Aggregation of Expanded Polyglutamine Proteins as Therapeutic Targets of the Polyglutamine Diseases: Exposed β-Sheet Hypothesis
- (2008) Yoshitaka Nagai et al. CURRENT PHARMACEUTICAL DESIGN
- RNA toxicity is a component of ataxin-3 degeneration in Drosophila
- (2008) Ling-Bo Li et al. NATURE
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
- (2008) Dagmar E Ehrnhoefer et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Polyglutamine neurodegeneration: protein misfolding revisited
- (2008) Aislinn J. Williams et al. TRENDS IN NEUROSCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search